NCT06297629 2026-05-15A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell TransplantationM.D. Anderson Cancer CenterPhase 2 Withdrawn